NIH study shows treatment benefits extend to infants born at 34-36 weeks.
Bethesda, Maryland–(ENEWSPF)–February 4, 2016. Prenatal steroid therapy reduces the chance of respiratory complications among infants born at 34-36 weeks, so-called “late” preterm infants, according to a study by a National Institutes of Health research network.
Steroids are a standard treatment for women likely to deliver before 34 weeks of pregnancy because these drugs are known to reduce respiratory and other complications, as well…
